STOCK TITAN

Dermtech Inc Stock Price, News & Analysis

DMTKQ OTC

Welcome to our dedicated page for Dermtech news (Ticker: DMTKQ), a resource for investors and traders seeking the latest updates and insights on Dermtech stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Dermtech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Dermtech's position in the market.

Rhea-AI Summary

DermTech (OTC: DMTKQ) has completed its Asset Purchase Agreement with DERM-JES Holdings, , resulting in the sale of substantially all of the company's assets. The new entity, DermTech, , will continue operations as a private company, focusing on precision dermatology and non-invasive skin genomics solutions. Led by dermatologists, dermatopathologists, and experienced professionals, the company will maintain its laboratory in San Diego, CA, and continue processing orders for the DermTech Melanoma Test (DMT).

The transaction was approved by the U.S. Bankruptcy Court for the District of Delaware on August 15, 2024, under Section 363 of the U.S. Bankruptcy Code. DermTech does not expect its stockholders to receive value from the sale or the Chapter 11 process. The company will cease all operations except those related to the bankruptcy and dissolution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.37%
Tags
none

FAQ

What is the current stock price of Dermtech (DMTKQ)?

The current stock price of Dermtech (DMTKQ) is $0.000001 as of August 12, 2025.

What is the market cap of Dermtech (DMTKQ)?

The market cap of Dermtech (DMTKQ) is approximately 3.5K.
Dermtech Inc

OTC:DMTKQ

DMTKQ Rankings

DMTKQ Stock Data

3.50k
34.28M
1.96%
5.65%
8.64%
Diagnostics & Research
Healthcare
Link
United States
San Diego